Zhiwei Wang

发表

Virtual Screening and Molecular Dynamics Study on Blockage of Key Drug Targets as Treatment for COVID-19 caused by SARS-CoV-2

Jun Zhang, Xiaohui Ma, Shu-yi Zhou, 2020 .

An Ultrapotent Neutralizing Bispeci c Antibody with Broad Spectrum Against SARS-CoV-2 Variants

Yaochang Yuan, Rong Li, Yanqun Wang, 2021 .

Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis

Yi-da Yang, Yafeng Yu, Huajiang Shen, 2016, Cellular Physiology and Biochemistry.

Exploring the Resistance Mechanisms of Distal D835V Mutation in FLT3 to Inhibitors

Jian Wang, Baichun Hu, Zhiwei Wang, 2022, Oxidative medicine and cellular longevity.

An ultrapotent neutralizing bispecific antibody with broad spectrum against SARS-CoV-2 variants

Cuihua Liu, Yaochang Yuan, Rong Li, 2021, bioRxiv.

MiR‐155 regulates M2 polarization of hepatitis B virus‐infected tumour‐associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma

Youlin Yu, Huajiang Shen, Zhiwei Wang, 2023, Journal of viral hepatitis.

Changes in COVID-19 vaccine hesitancy at different times among residents in Guangzhou, China

Jiachun Lu, Ling Lu, Tiegang Li, 2023, Frontiers in Public Health.

miR-202 functions as a tumor suppressor in hepatocellular carcinoma by targeting HK2

Yafeng Yu, Huajiang Shen, F. Ding, 2020, Oncology Letters.

Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses.

Yongxin Yu, Zhiwei Wang, L. Jia, 2003, Chinese medical journal.